Received: 12 March 2023
Accepted: 26 May 2023
First Online: 1 June 2023
: The present study approved by the ethics committee of Larestan University of Medical Sciences (Approval ID: IR.LARUMS.REC.1399.017). After assigning the participants to the two groups of intervention and control, informed consent was obtained from them and in all stages of the study, and the participants were ensured that their information would remain confidential. All methods were carried out in accordance with declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.